These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18290335)

  • 1. Biosensor for diagnosing Factor V Leiden, a single amino acid mutated abnormality of Factor V.
    Ren Y; Rezania S; Kang KA
    Adv Exp Med Biol; 2008; 614():245-52. PubMed ID: 18290335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near real-time immuno-optical sensor for diagnosing single point mutation: a model system: sensor for factor V Leiden diagnosis.
    Kang KA; Ren Y; Sharma VR; Peiper SC
    Biosens Bioelectron; 2009 May; 24(9):2785-90. PubMed ID: 19318242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of Factor V Leiden molecule, a mutated form of Factor V, from plasma of homozygous patient.
    Rezania S; Kang KA
    Adv Exp Med Biol; 2008; 614():101-7. PubMed ID: 18290319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.
    Eitzman DT; Westrick RJ; Shen Y; Bodary PF; Gu S; Manning SL; Dobies SL; Ginsburg D
    Circulation; 2005 Apr; 111(14):1822-5. PubMed ID: 15809370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
    Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
    Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden.
    Lincz LF; Scorgie FE; Enjeti A; Seldon M
    Thromb Res; 2012 Feb; 129(2):192-6. PubMed ID: 21798575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a cost-effective unlabeled probe high-resolution melt assay for genotyping of Factor V Leiden.
    Svensson AM; Chou LS; Meadows C; Miller CE; Palais R; Sumner K; Wayman TC; Mao R; Lyon E
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):207-13. PubMed ID: 21254846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns.
    Hyytiäinen S; Wartiovaara-Kautto U; Ulander VM; Kaaja R; Heikinheimo M; Petäjä J
    Thromb Haemost; 2006 Mar; 95(3):434-40. PubMed ID: 16525570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study.
    Schouten M; van't Veer C; Roelofs JJ; Levi M; van der Poll T
    Crit Care; 2010; 14(4):R145. PubMed ID: 20682036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of alpha-galactosidase A deficiency on FV leiden fibrin deposition and thrombosis in mice].
    Shen YC; He ZC; Cai RL; Pan JZ; Wang XM; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):162-5. PubMed ID: 19642363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergistic effect of deficiency in thrombosis-related genes].
    Shen YC; Luo BH; Ou BR; Chen AL; Wang XM; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):246-9. PubMed ID: 20533258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Cooley BC; Chen CY; Schmeling G
    Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the evolutionary advantage of coagulation factor V Leiden (FVL).
    Lindqvist PG
    Curr Med Chem; 2015; 22(32):3676-81. PubMed ID: 26423085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of factor V Leiden mutation and R2 polymorphism in cis position.
    Oztürk A; Balli S; Akar N
    Clin Appl Thromb Hemost; 2013; 19(6):685-8. PubMed ID: 22589460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza.
    Schouten M; van der Sluijs KF; Roelofs JJ; Levi M; Van't Veer C; van der Poll T
    Eur Respir J; 2010 Dec; 36(6):1346-54. PubMed ID: 20413539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.